3623 results for «2498»
3623 results
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
PCR e-Course Hot lines on TAVI – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
A patient with LAD-diagonal bifurcation lesion
22 May 2019 – From EuroPCR 2019
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
TAVI basics Co-Medicals - in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.
My best and worst cases of vascular access
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn thanks to a selection of challenging transcatheter aortic valve implantation cases how to analyse the access sites required, how to manage difficult access and complications, and discover some new approaches.
Abstracts in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various abstracts in TAVI, such as: combination of malnutrition and muscle weakness deteriorates clinical outcomes after TAVR, 3D printed silicone casted TAVI training simulator, TAVR with the new balloon-expandable SAPIEN 3 Ultra vs. SAPIEN 3 valve system, and more!
Aortic Valve Thrombosis
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.
Cases in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging TAVI cases, such as: subacute occlusion of right coronary artery after surgical aortic valve replacement, large post-myocardial infarction ventricular septum defect closure, NSTEMI after complex PCI and transfemoral TAVI procedure, and more!
Shared decision making in low-risk patients with aortic stenosis
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!
Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!
PCR Tokyo Valves 2020: Selection of the best abstracts
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best abstracts submitted at PCR Tokyo Valves 2020: the efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy, inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve, and more!
MitraClip and challenging anatomies
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn from a selection of challenging Mitraclip cases, how to avoid and cope with various complications, such as single-leaflet device attachment and leaflet tear, mitral stenosis, chordal entanglement, and more!
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
